3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
19
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Follicular
12
Lymphoma, Non-Hodgkin
11
Lymphoma, Mantle-Cell
8
Lymphoma, B-Cell, Marginal Zone
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Waldenstrom Macroglobulinemia
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Large-Cell, Anaplastic
3
Burkitt Lymphoma
3
Lymphoma, B-Cell
2
Leukemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Orbital lymphoma
1
Oncology Patients Receiving Chemotherapy
1
Neoplasms by Histologic Type
1
Neoplasms
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphatic Diseases
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Graft vs Host Disease
1
Interventions
Dexamethasone
32
Cyclophosphamide
30
fludarabine phosphate
25
Melphalan
25
Busulfan
25
Bortezomib
21
Tacrolimus
20
Lenalidomide
19
Peripheral Blood Stem Cell Transplantation
18
Mycophenolic Acid
17
Whole-Body Irradiation
16
Antilymphocyte Serum
16
fludarabine
14
Calcium Dobesilate
13
Thalidomide
12
Filgrastim
12
Granulocyte Colony-Stimulating Factor
11
Methotrexate
10
pomalidomide
9
Cyclosporine
8
Radiotherapy
6
Etoposide
6
Cord Blood Stem Cell Transplantation
6
Surveys and Questionnaires
5
Stem Cell Transplantation
5
Rituximab
5
Methylprednisolone
5
sargramostim
4
carfilzomib
4
Sirolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Plasma Cell
×
ibritumomab tiuxetan
×
Clear all
No trials found.